Citing increased input cost guidance for 2011, Goldman Sachs (NYSE:GS) lowered their price target and EPS estimates on Dr Pepper Snapple (NYSE:DPS).
For full year 2011, EPS estimate was dropped from $3.02 to $2.90, while its full year 2012 estimate fell from $3.30 to $3.18. Consensus on the Street for full year 2011 EPS estimate is $2.80.
Goldman maintains a "Neutral" rating on Dr Pepper Snapple, which closed Friday at $35.16, down $0.51, or 1.43 percent. They cut their price target on them from $41 to $39.
No comments:
Post a Comment